Cambridge Investment Research Advisors
XBI icon

Cambridge Investment Research Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.37M Sell
52,726
-6,816
-11% -$565K 0.01% 932
2025
Q1
$4.83M Sell
59,542
-5,860
-9% -$475K 0.02% 826
2024
Q4
$5.89M Sell
65,402
-5,726
-8% -$516K 0.02% 714
2024
Q3
$7.03M Buy
71,128
+2,250
+3% +$222K 0.02% 635
2024
Q2
$6.39M Sell
68,878
-7,297
-10% -$677K 0.02% 642
2024
Q1
$7.23M Buy
76,175
+10,176
+15% +$966K 0.03% 579
2023
Q4
$5.89M Sell
65,999
-11,130
-14% -$994K 0.03% 623
2023
Q3
$5.63M Sell
77,129
-34,096
-31% -$2.49M 0.03% 600
2023
Q2
$9.25M Buy
111,225
+36,234
+48% +$3.01M 0.04% 407
2023
Q1
$5.72M Buy
74,991
+6,872
+10% +$524K 0.03% 571
2022
Q4
$5.65M Sell
68,119
-829
-1% -$68.8K 0.03% 555
2022
Q3
$5.47M Sell
68,948
-125,447
-65% -$9.95M 0.03% 529
2022
Q2
$14.4M Buy
194,395
+140,122
+258% +$10.4M 0.08% 248
2022
Q1
$4.88M Sell
54,273
-15,238
-22% -$1.37M 0.02% 643
2021
Q4
$7.78M Buy
69,511
+7,109
+11% +$796K 0.03% 472
2021
Q3
$7.85M Buy
62,402
+128
+0.2% +$16.1K 0.04% 431
2021
Q2
$8.43M Sell
62,274
-18,836
-23% -$2.55M 0.04% 423
2021
Q1
$11M Buy
81,110
+5,681
+8% +$771K 0.06% 304
2020
Q4
$10.6M Buy
75,429
+16,502
+28% +$2.32M 0.06% 291
2020
Q3
$6.57M Buy
58,927
+3,664
+7% +$408K 0.04% 383
2020
Q2
$6.19M Buy
55,263
+18,149
+49% +$2.03M 0.05% 377
2020
Q1
$2.87M Sell
37,114
-11,029
-23% -$854K 0.03% 531
2019
Q4
$4.58M Buy
48,143
+7,639
+19% +$727K 0.04% 499
2019
Q3
$3.09M Sell
40,504
-861
-2% -$65.6K 0.03% 591
2019
Q2
$3.63M Buy
41,365
+346
+0.8% +$30.3K 0.03% 513
2019
Q1
$3.71M Buy
41,019
+2,083
+5% +$189K 0.04% 473
2018
Q4
$2.79M Sell
38,936
-30,980
-44% -$2.22M 0.03% 520
2018
Q3
$6.7M Sell
69,916
-13,919
-17% -$1.33M 0.06% 292
2018
Q2
$7.98M Buy
83,835
+44,412
+113% +$4.23M 0.08% 233
2018
Q1
$3.46M Buy
39,423
+13,718
+53% +$1.2M 0.04% 427
2017
Q4
$2.18M Sell
25,705
-8,277
-24% -$703K 0.03% 556
2017
Q3
$2.94M Buy
33,982
+7,796
+30% +$675K 0.04% 411
2017
Q2
$2.02M Buy
26,186
+3,212
+14% +$248K 0.03% 514
2017
Q1
$1.59M Buy
22,974
+724
+3% +$50.2K 0.03% 526
2016
Q4
$1.32M Buy
22,250
+9,027
+68% +$534K 0.02% 564
2016
Q3
$877K Sell
13,223
-223
-2% -$14.8K 0.02% 745
2016
Q2
$727K Buy
13,446
+437
+3% +$23.6K 0.02% 757
2016
Q1
$672K Sell
13,009
-532
-4% -$27.5K 0.02% 750
2015
Q4
$951K Buy
13,541
+1,017
+8% +$71.4K 0.02% 565
2015
Q3
$780K Buy
12,524
+3,195
+34% +$199K 0.02% 567
2015
Q2
$2.35M Sell
9,329
-511
-5% -$129K 0.07% 283
2015
Q1
$2.22M Buy
9,840
+1,737
+21% +$392K 0.06% 293
2014
Q4
$1.51M Buy
8,103
+1,299
+19% +$242K 0.05% 361
2014
Q3
$1.06M Sell
6,804
-139
-2% -$21.7K 0.03% 499
2014
Q2
$1.07M Sell
6,943
-31,618
-82% -$4.87M 0.04% 440
2014
Q1
$5.49M Buy
38,561
+23,427
+155% +$3.34M 0.21% 105
2013
Q4
$1.97M Buy
15,134
+3,419
+29% +$445K 0.08% 240
2013
Q3
$1.51M Buy
11,715
+2,259
+24% +$292K 0.07% 270
2013
Q2
$986K Buy
+9,456
New +$986K 0.05% 324